Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Niagen Bioscience Inc (NAGE)

Niagen Bioscience Inc (NAGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 508,364
  • Shares Outstanding, K 79,806
  • Annual Sales, $ 99,600 K
  • Annual Income, $ 8,550 K
  • EBIT $ 19 M
  • EBITDA $ 20 M
  • 60-Month Beta 2.31
  • Price/Sales 5.22
  • Price/Cash Flow 110.23
  • Price/Book 7.36

Options Overview Details

View History
  • Implied Volatility 114.28% (-7.49%)
  • Historical Volatility 35.79%
  • IV Percentile 85%
  • IV Rank 23.54%
  • IV High 313.09% on 12/12/25
  • IV Low 53.07% on 06/27/25
  • Expected Move (DTE 3) 1.06 (16.81%)
  • Put/Call Vol Ratio 3.00
  • Today's Volume 8
  • Volume Avg (30-Day) 152
  • Put/Call OI Ratio 0.88
  • Today's Open Interest 12,451
  • Open Int (30-Day) 13,283
  • Expected Range 5.26 to 7.38

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 0.01
  • Number of Estimates 2
  • High Estimate 0.02
  • Low Estimate 0.01
  • Prior Year 0.03
  • Growth Rate Est. (year over year) -66.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.26 +0.08%
on 12/16/25
7.11 -11.95%
on 11/20/25
-0.61 (-8.81%)
since 11/14/25
3-Month
6.26 +0.08%
on 12/16/25
10.52 -40.45%
on 09/23/25
-3.22 (-33.98%)
since 09/16/25
52-Week
5.16 +21.41%
on 01/07/25
14.69 -57.35%
on 06/30/25
+0.11 (+1.87%)
since 12/16/24

Most Recent Stories

More News
Niagen Bioscience Launches Tru Niagen® Beauty — The First NAD+ Skincare Supplement in the U.S. Featuring Niagen® (Patented Nicotinamide Riboside)

This science-backed blend of Niagen and clinically studied actives is designed to support healthy skin, hair, and nails

NAGE : 6.28 (-1.41%)
Niagen Bioscience Announces Results from First-Ever Randomized Controlled Trial Exploring Niagen (Patented Nicotinamide Riboside, NR) Supplementation in Long COVID

Findings show a significant increase in NAD+ levels and within-group benefits in fatigue, depression, and sleep quality

NAGE : 6.28 (-1.41%)
Niagen Bioscience Announces $10 Million Share Repurchase Program

Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced that its Board of Directors...

NAGE : 6.28 (-1.41%)
Niagen Bioscience: Q3 Earnings Snapshot

Niagen Bioscience: Q3 Earnings Snapshot

NAGE : 6.28 (-1.41%)
Niagen Bioscience, Inc. Reports Third Quarter 2025 Financial Results and Reaffirms Increased Full Year Outlook

Net sales increased 33% to $34.0 million Gross margin increased 100 bps to 64.5% Net income of $4.6 million, up $2.7 million ...

NAGE : 6.28 (-1.41%)
Niagen Bioscience to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025

Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, announces that it will hold a conference call...

NAGE : 6.28 (-1.41%)
Niagen Bioscience (NAGE) Gets a Buy from Canaccord Genuity

In a report released today, Susan Anderson from Canaccord Genuity reiterated a Buy rating on Niagen Bioscience, with a price target of $16.00. The company’s shares closed yesterday at $7.26.Elevate Your...

NAGE : 6.28 (-1.41%)
Niagen Bioscience (NAGE) Receives a Buy from Roth MKM

In a report released today, Sean McGowan from Roth MKM maintained a Buy rating on Niagen Bioscience, with a price target of $23.00. The company’s shares closed yesterday at $7.26.Elevate Your Investing...

NAGE : 6.28 (-1.41%)
Niagen Bioscience (NAGE) Receives a Buy from H.C. Wainwright

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Niagen Bioscience today and set a price target of $12.00. The company’s shares closed yesterday at $7.26.Elevate Your Investing Strategy:...

NAGE : 6.28 (-1.41%)
Niagen Bioscience Raises 2025 Sales Outlook Amid FDA Ruling

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The latest...

NAGE : 6.28 (-1.41%)

Business Summary

Niagen Bioscience Inc. is a nicotinamide adenine dinucleotide science and healthy-aging research company. Niagen Bioscience Inc., formerly known as ChromaDex Corp., is based in LOS ANGELES.

See More

Key Turning Points

3rd Resistance Point 6.81
2nd Resistance Point 6.72
1st Resistance Point 6.54
Last Price 6.28
1st Support Level 6.27
2nd Support Level 6.18
3rd Support Level 6.00

See More

52-Week High 14.69
Fibonacci 61.8% 11.05
Fibonacci 50% 9.92
Fibonacci 38.2% 8.80
Last Price 6.28
52-Week Low 5.16

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar